Genetic Testing for Prostate Cancer in Newcastle
Genetic testing for prostate cancer can help identify whether inherited gene changes may be contributing to a person’s prostate cancer risk or diagnosis. It may also help guide treatment planning for selected patients with prostate cancer.
Tyneside Urology Partners provides private assessment for genetic testing for prostate cancer in Newcastle. Suitability depends on your personal history, family history, cancer diagnosis, previous test results and specialist consultation.
What is genetic testing for prostate cancer?
Genetic testing looks for changes in genes that may increase the risk of developing certain cancers, including prostate cancer. These changes are sometimes inherited, meaning they can be passed down through families.
For prostate cancer, genetic testing may be considered in two main situations. Some patients may have testing because they have a personal or family history suggesting inherited cancer risk. Others may have testing after a prostate cancer diagnosis because the result could help guide treatment discussions.
Genetic testing is usually carried out using a blood or saliva sample, depending on the pathway used. The sample is sent to a specialist laboratory for analysis.
A genetic test does not diagnose prostate cancer on its own. It also does not predict with certainty whether someone will or will not develop cancer. Instead, it provides information that may help clinicians understand risk, guide treatment planning or advise whether family members may benefit from further assessment.
Because results can have implications for you and your relatives, genetic testing should be considered carefully with appropriate counselling and specialist guidance.
Why genetic testing may be recommended
Genetic testing may be recommended when there is a concern that prostate cancer risk could be linked to an inherited gene change. This may be based on personal cancer history, age at diagnosis, type of prostate cancer or patterns of cancer in the family.
Some inherited gene changes are linked with a higher risk of prostate cancer. These may also be linked with other cancers, such as breast, ovarian, pancreatic or bowel cancer, depending on the gene involved.
For patients already diagnosed with prostate cancer, genetic testing may sometimes help guide discussions about treatment options, clinical trial suitability or future monitoring. Whether this is relevant depends on the individual diagnosis and the type of test being considered.
Genetic testing is not needed for every man with prostate symptoms, raised PSA or prostate cancer. Your clinician will explain whether testing is appropriate and what the result may or may not change.
Who genetic testing for prostate cancer is for
Genetic testing for prostate cancer may be suitable for selected patients after specialist assessment. It may be helpful to discuss genetic testing if you:
- Have prostate cancer diagnosed at a younger age
- Have advanced or higher-risk prostate cancer
- Have a strong family history of prostate cancer
- Have relatives with breast, ovarian, pancreatic or bowel cancer
- Have several relatives affected by cancer on the same side of the family
- Have a known inherited cancer gene change in the family
- Have prostate cancer and want to understand whether genetics may affect treatment planning
- Have been advised to consider genetic testing by a specialist
- Are concerned about hereditary prostate cancer risk
- Want to understand whether relatives may need risk assessment
Genetic testing is not the right next step for everyone. Your clinician will consider your history, diagnosis and family background before advising whether testing is appropriate.
Concerns genetic testing can help assess
Genetic testing may help answer specific questions about inherited prostate cancer risk or treatment planning. It should be used alongside a full clinical assessment, not as a standalone test.
If several close relatives have had prostate cancer, particularly at a younger age, genetic testing may be discussed. Your clinician will look at which relatives were affected, their ages at diagnosis and whether other cancers are present in the family.
Some patients with prostate cancer may be offered genetic testing as part of treatment planning. This is more likely in selected cases, depending on the cancer type, stage, grade and available treatment options.
If a close relative has already been found to carry an inherited cancer gene change, testing may help clarify whether you carry the same change. This can guide personal risk assessment and family discussions.
A genetic test result may sometimes have implications for family members. If an inherited gene change is found, relatives may be able to seek genetic counselling or risk assessment through appropriate services.
Genetic testing is not a replacement for PSA testing, prostate MRI or biopsy where these are clinically needed. However, it may add useful information in selected patients when assessing overall prostate cancer risk.
What to expect
Genetic testing for prostate cancer is usually arranged after a detailed discussion. Your clinician will explain why testing may be considered, what the result could mean and whether further specialist genetic counselling is needed.
You will begin with a consultation to discuss your personal history, prostate cancer diagnosis if relevant, previous PSA results, prostate MRI findings, biopsy results and treatment history.
Your clinician may also ask about your family history. This may include relatives with prostate cancer, breast cancer, ovarian cancer, pancreatic cancer, bowel cancer or other cancers. They may ask which side of the family was affected and the age at which relatives were diagnosed.
This information helps decide whether genetic testing is appropriate and whether a referral to a specialist genetics service is needed.
Before testing, your clinician will explain what the test is looking for, what type of sample is needed and what the possible results could mean.
The discussion may include:
- Why genetic testing is being considered
- What genes may be included in the test
- Whether the test is looking for inherited or tumour-related changes
- What a positive, negative or uncertain result may mean
- Possible implications for relatives
- How results may affect treatment or monitoring
- Whether genetic counselling is recommended
- How long results may take, depending on the pathway
You should have time to ask questions before deciding whether to proceed.
Genetic testing usually involves a blood or saliva sample. The sample is sent to a specialist laboratory for analysis.
The sample collection itself is usually straightforward. The main consideration is not the sample process, but understanding the possible meaning and implications of the result.
Your results should be explained by an appropriately trained clinician or genetics specialist. The result may show:
- No clearly identified inherited gene change
- A gene change known to be linked with increased cancer risk
- A result of uncertain significance, where the meaning is not yet clear
Your clinician will explain what the result means for your prostate care and whether further action is recommended.
Next steps depend on the result and why the test was done. For some people, the result may not change immediate treatment. For others, it may influence treatment discussions, monitoring or whether relatives should consider genetic advice.
Your clinician will explain the next step in the context of your overall prostate health, cancer diagnosis or family history.
Benefits of genetic testing for prostate cancer
Genetic testing can provide useful information for selected patients, but it should be used carefully and with appropriate guidance.
Helps identify inherited cancer risk
Testing may help identify inherited gene changes that increase the risk of prostate cancer or other cancers. This can support more informed discussions about risk and monitoring.
May guide treatment planning
For some patients with prostate cancer, genetic information may help guide treatment discussions. This depends on the type of cancer, test result and available treatment options.
Can support family risk assessment
If an inherited gene change is found, close relatives may be able to seek advice about their own risk. This does not mean relatives will definitely develop cancer.
Adds context to prostate cancer assessment
Genetic testing can be considered alongside PSA, MRI, biopsy results, cancer stage, cancer grade, family history and general health.
Supports shared decision-making
A clear discussion about genetic risk can help patients make informed decisions about testing, treatment and family communication.
Risks and limitations
Genetic testing is usually low risk physically, but the results can have emotional, practical and family implications. Your clinician will explain these before testing.
Possible risks and limitations may include:
- Anxiety while waiting for results
- Distress if an inherited gene change is found
- Uncertainty if the result is unclear
- A negative result not removing all cancer risk
- A positive result not meaning cancer is certain to develop
- Possible implications for relatives
- Need for genetic counselling or further specialist advice
- Results that do not change immediate treatment options
- Need to interpret results alongside clinical findings
- Questions about privacy, consent and information sharing
Genetic testing should not be presented as a simple yes or no answer. It provides information that needs careful interpretation.
Your clinician will discuss what the result could mean before any test is arranged.
Alternatives to genetic testing
Genetic testing is only one part of prostate cancer risk assessment or treatment planning. Alternatives or related assessments may include:
- Prostate health check
- PSA blood testing
- Digital rectal examination
- Prostate MRI scan
- Transperineal prostate biopsy
- Review of family history without genetic testing
- Monitoring of PSA or symptoms over time
- Standard prostate cancer treatment planning based on diagnosis and staging
- Referral to a specialist genetics service where appropriate
If you have urinary symptoms or a raised PSA, genetic testing is not usually the first or only test. Your clinician will explain which assessment is most relevant to your situation.
Private genetic testing for prostate cancer near Newcastle
Tyneside Urology Partners provides private assessment for genetic testing for prostate cancer near Newcastle from its clinic in Team Valley, Tyne & Wear. The clinic serves patients from Newcastle, Gateshead, Tyneside and across the North East.
A consultation gives you the opportunity to discuss prostate cancer diagnosis, raised PSA, family history and inherited cancer risk in a specialist setting. Your clinician can explain whether genetic testing may be appropriate and how the result could influence your care or wider family risk assessment.
Frequently asked questions
- Who should consider genetic testing for prostate cancer?
Genetic testing may be considered for selected patients with prostate cancer, a strong family history of prostate cancer or a known inherited cancer gene change in the family. It is not needed for everyone. A specialist assessment can help decide whether testing is appropriate.
- Can genetic testing tell me if I will get prostate cancer?
No. Genetic testing cannot say with certainty whether you will or will not develop prostate cancer. It can identify some inherited gene changes linked with increased risk, but risk also depends on other factors.
- Is genetic testing the same as a PSA test?
No. A PSA test measures prostate specific antigen in the blood and is used as part of prostate assessment. Genetic testing looks for inherited or cancer-related gene changes. The two tests provide different types of information.
- Can genetic testing guide prostate cancer treatment?
In some selected patients, genetic test results may help guide treatment discussions. This depends on the diagnosis, stage of cancer, type of test and result. Your clinician will explain whether it is relevant to your treatment planning.
- What happens if a gene change is found?
If an inherited gene change is found, your clinician may discuss what it means for your own care and whether relatives should consider genetic advice. Further counselling or referral to a genetics service may be recommended.
- Can I have genetic testing for prostate cancer in Newcastle?
Tyneside Urology Partners provides private assessment for genetic testing for prostate cancer near Newcastle. Your clinician can advise whether testing is suitable based on your diagnosis, personal history and family history.
Understand your prostate cancer risk in Newcastle
If you have prostate cancer, a raised PSA or a family history of prostate cancer, specialist assessment can help you understand whether genetic testing may be relevant.
